Ignite Creation Date:
2025-12-24 @ 3:52 PM
Ignite Modification Date:
2026-01-28 @ 5:26 AM
Study NCT ID:
NCT02867592
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-02
First Post:
2016-08-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Sponsor:
Organization: